Brief: Brainstorm Cell Therapeutics Approves One-For-Fifteen Reverse Stock Split Of Co's Common Stock
26/09/2024 22:03
Sept 26 (Reuters) - Brainstorm Cell Therapeutics Inc
BCLI.O :
* BRAINSTORM CELL THERAPEUTICS - APPROVED ONE-FOR-FIFTEEN
REVERSE
STOCK SPLIT OF CO'S COMMON STOCK
Source text for Eikon: ID:n0001104659-24-103157
Further company coverage: BCLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview